Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
Adaptive randomized study of idarubicin and cytarabine versus troxacitabine and cytarabine versus troxacitabine and idarubicin in untreated patients 50 years or older with adverse karyotype acute myeloid leukemia. [electronic resource] by
- Giles, Francis J
- Kantarjian, Hagop M
- Cortes, Jorge E
- Garcia-Manero, Guillermo
- Verstovsek, Srdan
- Faderl, Stefan
- Thomas, Deborah A
- Ferrajoli, Alessandra
- O'Brien, Susan
- Wathen, Jay K
- Xiao, Lian-Chun
- Berry, Donald A
- Estey, Elihu H
Producer: 20030520
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 21
Availability: No items available.
|